However, it is well known that many NMS are related to motor fluctuations and to dopamine deficiency and the fact that these symptoms improved with only 50 mg/day of safinamide as well suggests a role, at least in part, of its dopaminergic effect (MAO-B inhibitor). This evidence concerns the gene MAOB and neuroleptic malignant syndrome.